133 related articles for article (PubMed ID: 38232639)
1. Screening of natural inhibitors against peptidyl arginine deiminase 4 from herbal extracts by a high-performance liquid chromatography ultraviolet-visible based method.
Zhao J; Li Y; Gao C; Zhao Z; Zhang S; Dong J; Zuo H; Chen X; Xie B; Guo Z; Wang Y; Li H; Bian Y
J Chromatogr A; 2024 Feb; 1716():464643. PubMed ID: 38232639
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
Du M; Yang W; Schmull S; Gu J; Xue S
Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
[TBL] [Abstract][Full Text] [Related]
3. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.
Teo CY; Shave S; Chor AL; Salleh AB; Rahman MB; Walkinshaw MD; Tejo BA
BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S4. PubMed ID: 23282142
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new inhibitor for the protein arginine deiminase type 4 (PAD4) by rational design of α-enolase-derived peptides.
Ahmad Nadzirin I; Chor ALT; Salleh AB; Rahman MBA; Tejo BA
Comput Biol Chem; 2021 Jun; 92():107487. PubMed ID: 33957477
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.
Thirugnanasambandham I; Radhakrishnan A; Kuppusamy G; Kumar Singh S; Dua K
Biochem Pharmacol; 2022 Jun; 200():115040. PubMed ID: 35436466
[TBL] [Abstract][Full Text] [Related]
7. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Knuckley B; Luo Y; Thompson PR
Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Peptidyl Arginine Deiminase-4 Prevents Renal Ischemia-Reperfusion-Induced Remote Lung Injury.
Du M; Yang L; Gu J; Wu J; Ma Y; Wang T
Mediators Inflamm; 2020; 2020():1724206. PubMed ID: 33456369
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminases 4 as a promising target in drug discovery.
Yang C; Dong ZZ; Zhang J; Teng D; Luo X; Li D; Zhou Y
Eur J Med Chem; 2021 Dec; 226():113840. PubMed ID: 34520958
[TBL] [Abstract][Full Text] [Related]
10. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.
Koushik S; Joshi N; Nagaraju S; Mahmood S; Mudeenahally K; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Apr; 21(4):433-447. PubMed ID: 28281906
[TBL] [Abstract][Full Text] [Related]
11. Autocitrullination of PAD4 does not alter its enzymatic activity: In vitro and in silico studies.
Liu X; Wichapong K; Lamers S; Reutelingsperger CPM; Nicolaes GAF
Int J Biochem Cell Biol; 2021 May; 134():105938. PubMed ID: 33529715
[TBL] [Abstract][Full Text] [Related]
12. Screening of mammalian target of rapamycin inhibitors in natural product extracts by capillary electrophoresis in combination with high performance liquid chromatography-tandem mass spectrometry.
Zhang Y; Li F; Li M; Kang J
J Chromatogr A; 2015 Apr; 1388():267-73. PubMed ID: 25725958
[TBL] [Abstract][Full Text] [Related]
13. PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease.
Liu X; Arfman T; Wichapong K; Reutelingsperger CPM; Voorberg J; Nicolaes GAF
J Thromb Haemost; 2021 Jul; 19(7):1607-1617. PubMed ID: 33773016
[TBL] [Abstract][Full Text] [Related]
14. Facile fluorescence-based detection of PAD4-mediated citrullination.
Wildeman E; Pires MM
Chembiochem; 2013 May; 14(8):963-7. PubMed ID: 23640867
[TBL] [Abstract][Full Text] [Related]
15. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
Bozdag M; Dreker T; Henry C; Tosco P; Vallaro M; Fruttero R; Scozzafava A; Carta F; Supuran CT
Bioorg Med Chem Lett; 2013 Feb; 23(3):715-9. PubMed ID: 23265898
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells.
Chen H; Luo M; Wang X; Liang T; Huang C; Huang C; Wei L
Cell Mol Biol Lett; 2021 Mar; 26(1):9. PubMed ID: 33726680
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
18. Screening of inhibitors of glycogen synthase kinase-3β from traditional Chinese medicines using enzyme-immobilized magnetic beads combined with high-performance liquid chromatography.
Li Y; Xu J; Chen Y; Mei Z; Xiao Y
J Chromatogr A; 2015 Dec; 1425():8-16. PubMed ID: 26610618
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.
Tjin CC; Wissner RF; Jamali H; Schepartz A; Ellman JA
ACS Med Chem Lett; 2018 Oct; 9(10):1013-1018. PubMed ID: 30344909
[TBL] [Abstract][Full Text] [Related]
20. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
